Pyxis Oncology Initiates New PYX-201 Combination Trial and Initiates Cohort Expansions of Ongoing Monotherapy Trial
Initiation of Phase 1/2 combination trial with PYX-201, an extracellular ADC targeting Extradomain-B Fibronectin (EDB+FN) and ...
Pyxis Oncology initiates new PYX-201 trial, initiates cohort expansions
Pyxis Oncology (PYXS) announced significant progress in its clinical program for PYX-201, a first-in-concept antibody-drug conjugate, ADC, that ...
labmate-online.com16h
New website simplifies access for biotech and biopharma users
ProBioGen has launched its redesigned website, offering biotech and biopharma professionals streamlined access to its expanded services and proprietary technologies. The updated platform delivers ...